PRMT1 methylates METTL14 to modulate its oncogenic function

Jingchao Wang1, Zhen Wang1, Hiroyuki Inuzuka1

  • 1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Neoplasia (New York, N.Y.)
|June 3, 2023
PubMed

Insights

Protein arginine methyltransferase 1 (PRMT1) methylates METTL14, a key component of the m6A writer complex. This arginine methylation regulates m6A modification and promotes cell proliferation, suggesting a role in tumorigenesis.

Area of Science:

  • Epigenetics
  • RNA biology
  • Cancer research

Background:

  • N6-methyladenosine (m6A) is a crucial mRNA modification regulating stability and splicing.
  • The METTL3-METTL14-WTAP complex catalyzes m6A, but its upstream regulation is poorly understood.
  • Post-translational modifications, particularly arginine methylation, are implicated in regulating protein function.

Purpose of the Study:

  • To investigate the role of protein arginine methyltransferases (PRMTs) in regulating the m6A writer complex.
  • To identify upstream regulators of METTL14 function at the post-translational level.
  • To elucidate the impact of METTL14 arginine methylation on m6A modification and cellular processes.

Main Methods:

  • Investigated the interaction between PRMT1 and METTL14.
  • Identified specific arginine residues on METTL14 methylated by PRMT1.
  • Assessed the functional consequences of METTL14 arginine methylation on m6A modification and cell proliferation.
  • Utilized the PRMT1 inhibitor MS023 to study the effects of methylation inhibition.

Main Results:

  • PRMT1 directly methylates arginine residues in the C-terminus of METTL14.
  • The reader protein SPF30 recognizes PRMT1-mediated arginine methylation on METTL14.
  • PRMT1-dependent arginine methylation of METTL14 is essential for m6A modification.
  • Arginine methylation of METTL14 promotes cell proliferation, an effect inhibited by MS023.

Conclusions:

  • PRMT1-mediated arginine methylation of METTL14 is a novel regulatory mechanism for m6A modification.
  • This modification plays a significant role in promoting cell proliferation and tumorigenesis.
  • Targeting PRMT1 could be a potential therapeutic strategy for cancers associated with aberrant m6A modification.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.9K